Antares Pharma, Inc. (ATRS)

[jab91252]

I'd be shocked and surprised if Ali is stocklasar.

I just wrote a response to the article.

{An excellent "deep diving" article Mr.Yasar! Very well thought out, researched and presented. Personally, I'm on the fence about a Pfizer buyout given CEO Wotton's recent statement that they "are not for sale." As far as buyout l, I could argue that perhaps Antares would be open to sell off their 'Gel' side drug delivery platform while maintaining their expanding, revenue producing injector platform.

As you state and for all the right reasons, the future (starting with the route switch delivery to subcutaneous and self administration via Otrexup) ,is their injector technology platform with the delivery of well known drugs (methotrexate and testosterone) and eventually add on biologics and biosimilars which are slated to replace 70% of chemical drugs per GaBi Journal. And as you are aware, the abbreviated pathway for biosimilars per the Affordable Care Act that was signed into law in 2010 sets the stage for Antares to eventually secure their own market niche.}
jab9

Hope to see and read more articles from you.
jab9